Duactam

Duactam Adverse Reactions

Manufacturer:

Ajanta Pharma Phil

Distributor:

Ajanta Pharma Phil
Full Prescribing Info
Adverse Reactions
Tadalafil: The most commonly reported adverse reactions in patients taking Tadalafil for the treatment of benign prostatic hyperplasia were headache, dyspepsia, back pain and myalgia, in which the incidences increase with increasing dose of Tadalafil. The adverse reactions reported were transient, and generally mild or moderate. The majority of headaches reported with Tadalafil once-day dosing are experienced within the first 10 to 30 days of starting treatment.
Tabulated summary of adverse reactions: The table as follows lists the adverse reactions observed from spontaneous reporting and in placebo controlled clinical trials (comprising a total of 7116 patients on Tadalafil and 3718 patients on placebo) for on-demand and once-a-day treatment of erectile dysfunction and the once-a-day treatment of benign prostatic hyperplasia.
Frequency convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1000 to <1/100), rare (≥1/10,000 to <1/1,000) and very rare (<1/10,000) and not known (cannot be estimated from the available data). (See Table 1.)

Click on icon to see table/diagram/image

Tamsulosin: Tabulated list of adverse reactions: See Table 2.

Click on icon to see table/diagram/image

As with other alpha-blockers, drowsiness, blurred vision or edema can occur.
During cataract and glaucoma surgery a small pupil situation, known as Intraoperative Floppy Iris Syndrome (IFIS), has been associated with therapy of tamsulosin during post-marketing surveillance.
Post-marketing experience: In addition to the adverse events listed previously, atrial fibrillation, arrhythmia, tachycardia and dyspnea have been reported in association with tamsulosin use. Because these spontaneously reported events are from the worldwide post marketing experience, the frequency of events and the role of tamsulosin in their causation cannot be reliably determined.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in